The efficacy of L-carnitine in patients with nonalcoholic steatohepatitis and concomitant obesity


Zakharova N. Luo C. Aringazina R. Samusenkov V.
December 2023BioMed Central Ltd

Lipids in Health and Disease
2023#22Issue 1

Background: In light of the high prevalence of nonalcoholic fatty liver disease and obesity, treatment options for nonalcoholic steatohepatitis are of particular interest. The purpose of the study is to assess the efficacy of L-carnitine and its effects on the functional state of the liver, as well as on lipid and carbohydrate metabolism in patients with nonalcoholic steatohepatitis and concomitant obesity. Methods: People in the control group followed a hypocaloric diet and received 1 tablet of simvastatin 20 mg once a day and 2 capsules of essential phospholipids 600 mg three times a day for 90 days. People in the experimental group followed a hypocaloric diet and received 1 tablet of simvastatin 20 mg once a day and L-carnitine 10 mL orally two times a day for 90 days. Results: L-carnitine normalized the blood lipid profile of subjects, as demonstrated by a significant decrease in the blood levels of total cholesterol, triglycerides, low-density lipoproteins, atherogenic index, and insulin resistance. The use of L-carnitine in patients with nonalcoholic steatohepatitis and concomitant obesity contributes to the steady reduction of the main clinical and biochemical symptoms of nonalcoholic steatohepatitis. Conclusions: L-carnitine produces positive effects on the blood lipid profile and carbohydrate metabolism.

Carbohydrate metabolism , Improving insulin resistance in steatohepatitis , L-carnitine for the management of hyperlipidemia , Nonalcoholic steatohepatitis and concomitant obesity , The effects of L-carnitine on liver tests

Text of the article Перейти на текст статьи

Department of Chemistry, I.M. Sechenov First Moscow State Medical University (Sechenov University, Trubetskaya str., 8-2, Moscow, 119991, Russian Federation
Department of Hospital Therapy named after Academician G.I. Storozhakov of the Medical Faculty, Pirogov Russian National Research Medical University, Ostrovityanova str., 1, Moscow, 117997, Russian Federation
Department of Internal Diseases № 1, Non-Commercial Joint-Stock Society “West Kazakhstan Marat Ospanov Medical University”, Aleksey Maresyev str, Aktobe, 030019, Kazakhstan
Department of Prosthetic Dentistry, I.M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya str., 8-2, Moscow, 119991, Russian Federation

Department of Chemistry
Department of Hospital Therapy named after Academician G.I. Storozhakov of the Medical Faculty
Department of Internal Diseases № 1
Department of Prosthetic Dentistry

10 лет помогаем публиковать статьи Международный издатель

Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026